Jane Street Group, LLC Aldeyra Therapeutics, Inc. Transaction History

Jane Street Group, LLC

  • $445 Billion
  • Q3 2024

A detailed history of Jane Street Group, LLC transactions in Aldeyra Therapeutics, Inc. stock. As of the latest transaction made, Jane Street Group, LLC holds 23,731 shares of ALDX stock, worth $139,775. This represents 0.0% of its overall portfolio holdings.

Number of Shares
23,731
Previous 93,146 74.52%
Holding current value
$139,775
Previous $308,000 58.77%
% of portfolio
0.0%
Previous 0.0%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
SELL
$3.19 - $6.32 $221,433 - $438,702
-69,415 Reduced 74.52%
23,731 $127,000
Q2 2024

Aug 14, 2024
BUY
$3.25 - $4.72 $302,724 - $439,649
93,146 New
93,146 $308,000
Q4 2023

Feb 14, 2024
SELL
$1.47 - $6.06 $94,235 - $388,482
-64,106 Reduced 48.41%
68,327 $239,000
Q3 2023

Nov 14, 2023
BUY
$6.11 - $8.16 $475,266 - $634,725
77,785 Added 142.34%
132,433 $884,000
Q2 2023

Aug 14, 2023
SELL
$7.11 - $11.89 $1.53 Million - $2.55 Million
-214,882 Reduced 79.72%
54,648 $458,000
Q1 2023

May 15, 2023
BUY
$5.77 - $9.93 $1.19 Million - $2.05 Million
206,348 Added 326.59%
269,530 $2.68 Million
Q4 2022

Feb 14, 2023
BUY
$5.08 - $7.09 $320,964 - $447,960
63,182 New
63,182 $439,000
Q2 2022

Aug 16, 2022
SELL
$2.43 - $4.85 $161,347 - $322,030
-66,398 Closed
0 $0
Q1 2022

May 17, 2022
SELL
$3.25 - $5.17 $262,788 - $418,035
-80,858 Reduced 54.91%
66,398 $295,000
Q4 2021

Feb 15, 2022
BUY
$3.5 - $9.63 $328,209 - $903,043
93,774 Added 175.34%
147,256 $589,000
Q3 2021

Nov 16, 2021
BUY
$7.94 - $11.31 $319,505 - $455,114
40,240 Added 303.88%
53,482 $469,000
Q2 2021

Aug 16, 2021
SELL
$10.44 - $14.85 $64,759 - $92,114
-6,203 Reduced 31.9%
13,242 $150,000
Q1 2021

May 18, 2021
SELL
$6.53 - $14.42 $399,080 - $881,278
-61,115 Reduced 75.86%
19,445 $231,000
Q4 2020

Feb 17, 2021
BUY
$6.31 - $8.13 $397,851 - $512,604
63,051 Added 360.11%
80,560 $553,000
Q3 2020

Nov 17, 2020
SELL
$4.0 - $7.53 $456,324 - $859,029
-114,081 Reduced 86.69%
17,509 $130,000
Q2 2020

Aug 17, 2020
BUY
$1.97 - $5.05 $259,232 - $664,529
131,590 New
131,590 $549,000
Q4 2017

Feb 15, 2018
SELL
$5.7 - $7.75 $62,477 - $84,947
-10,961 Closed
0 $0
Q3 2017

Nov 14, 2017
BUY
$3.9 - $10.8 $42,747 - $118,378
10,961
10,961 $79,000

Others Institutions Holding ALDX

# of Institutions
119
Shares Held
36.7M
Call Options Held
196K
Put Options Held
142K
View Full List

About Aldeyra Therapeutics, Inc.

ALDX Quotes by TradingView
  • Ticker ALDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 58,323,100
  • Market Cap $344M
  • Description
  • Aldeyra Therapeutics, Inc., a biotechnology company, develops and commercializes medicines for immune-mediated ocular and systemic diseases. The company's lead product candidate is reproxalap, a reactive aldehyde species (RASP)modulator, which is in Phase III clinical trial for the treatment of dry eye diseases and allergic conjunctivitis. It al...
More about ALDX
Track This Portfolio

Track Jane Street Group, LLC Portfolio

Follow Jane Street Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jane Street Group, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email